@inbook{4c5c7d0cd7a3477c9f1e5e9e8cf79ff6,
title = "Nanomedicines: Addressing the scientific and regulatory gap",
keywords = "Abbreviated new drug application (anda), Abraxane{\textregistered}, Bayh-dole act, Bioequivalence, Biosimilars, Commercialization, Doxil{\textregistered}, European medicines agency (ema), Fda regulation, Follow-on biologics, Food and drug administration (fda), Immunogenicity, Invention, Monoclonal antibodies (mabs), Nanomedicine, Nanopharmaceuticals, Nanosimilars, Nanotechnology, Nanotechnology characterization laboratory (ncl), New drug application (nda), Non-biologic complex drug (nbcd), Patent classification, Patent laws, Patent thickets, Patents, Pharmacodynamics, Pharmacokinetics, Post-blockbuster world, Regulation, Us patent \& Trademark office (pto)",
author = "Sally Tinkle and McNeil, \{Scott E.\} and Stefan M{\"u}hlebach and Raj Bawa and Gerrit Borchard and Yechezkel Barenholz and Lawrence Tamarkin and Neil Desai",
year = "2016",
month = may,
day = "2",
doi = "10.4032/9789814669238",
language = "אנגלית",
isbn = "9789814669221",
volume = "2",
pages = "413--470",
booktitle = "Handbook of Clinical Nanomedicine",
publisher = "Pan Stanford Publishing Pte. Ltd.",
}